In 2013, a cross-sectional study examined leptin levels across three subtypes of adult-onset MS, RRMS, primary-progressive MS (PPMS), and secondary-progressive MS (SPMS), and compared them with healthy controls. Here, LEP is linked to myeloid sarcoma.